AnalystsDanielle BrillDanielle Brill's Stock Forecasts
AnalystsDanielle Brill
Analyst Ranking
Bottom 5%
#4378 out of 4565 analysts
Average Return
-15.66%
Win Rate
31%15 out of 49
Risk vs Reward
Poor
Good
Danielle Brill's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Sage Therapeutics IncSAGE | +149.76% | $70.20 | $175.33 | 2017-05-15 - 2018-05-16 | Buy |
Passage Bio IncPASG | +84.85% | $0.66 | $1.22 | 2023-11-13 - 2024-04-25 | Buy |
Acceleron Pharma IncXLRN | +48.10% | $79.39 | $117.58 | 2020-01-27 - 2021-01-28 | Strong Buy |
Global Blood Therapeutics IncGBT | +46.41% | $27.15 | $39.75 | 2017-09-20 - 2018-09-21 | Buy |
Harmony Biosciences Holdings IncHRMY | +41.04% | $42.50 | $59.94 | 2021-11-03 - 2022-11-03 | Buy |
Danielle Brill Analyst Color
Get additional color on Danielle Brill's coverage of popular stocks
Danielle Brill's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Argenx SeARGX | 6 | Strong Buy | $520.00 | +41.07% | Maintains | 4 months ago |
Biogen IncBIIB | 1 | Buy | $283.00 | +39.78% | Upgrades | 5 months ago |
Passage Bio IncPASG | 5 | Buy | $5.00 | +309.84% | Maintains | 5 months ago |
Neurocrine Biosciences IncNBIX | 4 | Buy | $145.00 | +5.26% | Maintains | 6 months ago |
Harmony Biosciences Holdings IncHRMY | 6 | Buy | $27.00 | -6.67% | Maintains | 6 months ago |
Immunovant IncIMVT | 3 | Buy | $40.00 | +44.14% | Upgrades | 7 months ago |
Ptc Therapeutics IncPTCT | 6 | Buy | $55.00 | +115.77% | Maintains | 9 months ago |
Uniqure NvQURE | 4 | Buy | $50.00 | +1,001.32% | Maintains | 9 months ago |
Disc Medicine IncIRON | 3 | Strong Buy | $75.00 | +182.81% | Upgrades | 10 months ago |
Fibrogen IncFGEN | 2 | Buy | $35.00 | N/A | Upgrades | a year ago |
Xenon Pharmaceuticals IncXENE | 1 | Buy | $52.00 | N/A | Initiates Coverage On | 2 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Agios Pharmaceuticals IncAGIO | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $35.00 | N/A | Downgrades | 3 years ago |
Global Blood Therapeutics IncGBT | 4 | Hold | $50.00 | N/A | Downgrades | 3 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Sarepta Therapeutics IncSRPT | 1 | Buy | $200.00 | N/A | Initiates Coverage On | 4 years ago |
Zogenix IncZGNX | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Buy | $28.00 | N/A | Assumes | 6 years ago |
Sage Therapeutics IncSAGE | 1 | Buy | $82.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.